{"disease":{"id":"antepartum-dvt","name":"antepartum dvt"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04635839","title":"Heparin Prophylaxis Dosing for Antepartum Hospitalizations (HEPDOSE)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"University of California, Los Angeles","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}